XML 32 R33.htm IDEA: XBRL DOCUMENT v3.20.1
Investments (Tables)
 3 Months Ended
Mar. 31, 2020
Equity Method Investments and Joint Ventures [Abstract]  
Equity Method Investments
The Company used the following summarized financial information for NantOmics for the three months ended December 31, 2019 and 2018, to record its equity method losses for the three months ended March 31, 2020 and 2019:
 
Three Months Ended
December 31
 
2019
 
2018
Revenues
$
223

 
$
1,746

Gross loss
(1,163
)
 
(520
)
Loss from operations
(3,856
)
 
(6,884
)
Impairment on equity investments
—

 
(12,265
)
Net loss
(1,360
)
 
(17,851
)
Net loss attributable to NantOmics
(1,329
)
 
(17,752
)